Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-25 @ 8:24 PM
Study NCT ID:
NCT06149169
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-08-21
First Post:
2023-11-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma
Sponsor:
Shanghai Ming Ju Biotechnology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-17
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-14
First Submit QC Date:
None
Study First Post Date:
2023-11-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-19
Last Update Post Date:
2024-08-21
Last Update Post Date Type:
ACTUAL